Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Adaptive Biotechnologies Corp See All Filings	D	2015-05-11 00:00:00 UTC
Amount To Be Raised $195,099,954 Associated Brokers / Dealers N/A CIK Number 0001478320 Filed Document 0001478320-15-000003 Exclusions or Exemptions 506b Accepted Date 2015-05-11 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Adaptive Biotechnologies Corp See All Filings	D	2015-01-21 00:00:00 UTC
Amount To Be Raised $95,716,444 Associated Brokers / Dealers N/A CIK Number 0001478320 Filed Document 0001478320-15-000001 Exclusions or Exemptions 506b Accepted Date 2015-01-21 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Adaptive Biotechnologies Corp See All Filings	D	2015-01-21 00:00:00 UTC
Amount To Be Raised $93,750,000 Associated Brokers / Dealers N/A CIK Number 0001478320 Filed Document 0001478320-15-000002 Exclusions or Exemptions 506b Accepted Date 2015-01-21 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Adaptive Biotechnologies Corp See All Filings	D/A	2014-07-29 00:00:00 UTC
Amount To Be Raised $106,999,480 Associated Brokers / Dealers N/A CIK Number 0001478320 Filed Document 0001478320-14-000002 Exclusions or Exemptions 506b Accepted Date 2014-07-29 00:00:00 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Adaptive Biotechnologies Corp See All Filings	D	2014-04-14 00:00:00 UTC
Amount To Be Raised $104,999,480 Associated Brokers / Dealers N/A CIK Number 0001478320 Filed Document 0001478320-14-000001 Exclusions or Exemptions 506b Accepted Date 2014-04-14 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity